[
    {
        "molecule_name": "antibody",
        "protein_target_name": "PD-1",
        "binding_metric": "Kd",
        "value": "≤1",
        "unit": "μM",
        "raw_mentions": "An antibody of the present invention can specifically bind to a PD-1 epitope when the equilibrium binding constant (K<sub>D</sub>) is ≤1 μM, ≤10 μM, ≤10 nM, ≤10 pM, or &lt;100 pM to about 1 pM, as measured by kinetic assays such as radioligand binding assays or similar assays known to those skilled in the art, such as BIAcore or Octet (BLI).\nFor example, in some embodiments, the K<sub>D </sub>is between about 1E-12 M and a K<sub>D </sub>about 1E-11 M.\nIn some embodiments, the K<sub>D </sub>is between about 1E-11 M and a K<sub>D </sub>about 1E-10 M.\nIn some embodiments, the K<sub>D </sub>is between about 1E-10 M and a K<sub>D </sub>about 1E-9 M.\nIn some embodiments, the K<sub>D </sub>is between about 1E-9 M and a K<sub>D </sub>about 1E-8 M.\nIn some embodiments, the K<sub>D </sub>is between about 1E-8 M and a K<sub>D </sub>about 1E-7 M.\nIn some embodiments, the K<sub>D </sub>is between about 1E-7 M and a K<sub>D </sub>about 1E-6 M.\nFor example, in some embodiments, the K<sub>D </sub>is about 1E-12 M while in other embodiments the K<sub>D </sub>is about 1E-11 M.\nIn some embodiments, the K<sub>D </sub>is about 1E-10 M while in other embodiments the K<sub>D </sub>is about 1E-9 M.\nIn some embodiments, the K<sub>D </sub>is about 1E-8 M while in other embodiments the K<sub>D </sub>is about 1E-7 M.\nIn some embodiments, the K<sub>D </sub>is about 1E-6 M while in other embodiments the K<sub>D </sub>is about 1E-5 M.\nIn some embodiments, for example, the K<sub>D </sub>is about 3 E-11 M, while in other embodiments the K<sub>D </sub>is about 3E-12 M."
    },
    {
        "molecule_name": "antibody",
        "protein_target_name": "PD-1",
        "binding_metric": "Kd",
        "value": "≤10",
        "unit": "μM",
        "raw_mentions": "An antibody of the present invention can specifically bind to a PD-1 epitope when the equilibrium binding constant (K<sub>D</sub>) is ≤1 μM, ≤10 μM, ≤10 nM, ≤10 pM, or &lt;100 pM to about 1 pM, as measured by kinetic assays such as radioligand binding assays or similar assays known to those skilled in the art, such as BIAcore or Octet (BLI).\nFor example, in some embodiments, the K<sub>D </sub>is between about 1E-12 M and a K<sub>D </sub>about 1E-11 M.\nIn some embodiments, the K<sub>D </sub>is between about 1E-11 M and a K<sub>D </sub>about 1E-10 M.\nIn some embodiments, the K<sub>D </sub>is between about 1E-10 M and a K<sub>D </sub>about 1E-9 M.\nIn some embodiments, the K<sub>D </sub>is between about 1E-9 M and a K<sub>D </sub>about 1E-8 M.\nIn some embodiments, the K<sub>D </sub>is between about 1E-8 M and a K<sub>D </sub>about 1E-7 M.\nIn some embodiments, the K<sub>D </sub>is between about 1E-7 M and a K<sub>D </sub>about 1E-6 M.\nFor example, in some embodiments, the K<sub>D </sub>is about 1E-12 M while in other embodiments the K<sub>D </sub>is about 1E-11 M.\nIn some embodiments, the K<sub>D </sub>is about 1E-10 M while in other embodiments the K<sub>D </sub>is about 1E-9 M.\nIn some embodiments, the K<sub>D </sub>is about 1E-8 M while in other embodiments the K<sub>D </sub>is about 1E-7 M.\nIn some embodiments, the K<sub>D </sub>is about 1E-6 M while in other embodiments the K<sub>D </sub>is about 1E-5 M.\nIn some embodiments, for example, the K<sub>D </sub>is about 3 E-11 M, while in other embodiments the K<sub>D </sub>is about 3E-12 M."
    },
    {
        "molecule_name": "antibody",
        "protein_target_name": "PD-1",
        "binding_metric": "Kd",
        "value": "≤10",
        "unit": "nM",
        "raw_mentions": "An antibody of the present invention can specifically bind to a PD-1 epitope when the equilibrium binding constant (K<sub>D</sub>) is ≤1 μM, ≤10 μM, ≤10 nM, ≤10 pM, or &lt;100 pM to about 1 pM, as measured by kinetic assays such as radioligand binding assays or similar assays known to those skilled in the art, such as BIAcore or Octet (BLI).\nFor example, in some embodiments, the K<sub>D </sub>is between about 1E-12 M and a K<sub>D </sub>about 1E-11 M.\nIn some embodiments, the K<sub>D </sub>is between about 1E-11 M and a K<sub>D </sub>about 1E-10 M.\nIn some embodiments, the K<sub>D </sub>is between about 1E-10 M and a K<sub>D </sub>about 1E-9 M.\nIn some embodiments, the K<sub>D </sub>is between about 1E-9 M and a K<sub>D </sub>about 1E-8 M.\nIn some embodiments, the K<sub>D </sub>is between about 1E-8 M and a K<sub>D </sub>about 1E-7 M.\nIn some embodiments, the K<sub>D </sub>is between about 1E-7 M and a K<sub>D </sub>about 1E-6 M.\nFor example, in some embodiments, the K<sub>D </sub>is about 1E-12 M while in other embodiments the K<sub>D </sub>is about 1E-11 M.\nIn some embodiments, the K<sub>D </sub>is about 1E-10 M while in other embodiments the K<sub>D </sub>is about 1E-9 M.\nIn some embodiments, the K<sub>D </sub>is about 1E-8 M while in other embodiments the K<sub>D </sub>is about 1E-7 M.\nIn some embodiments, the K<sub>D </sub>is about 1E-6 M while in other embodiments the K<sub>D </sub>is about 1E-5 M.\nIn some embodiments, for example, the K<sub>D </sub>is about 3 E-11 M, while in other embodiments the K<sub>D </sub>is about 3E-12 M."
    },
    {
        "molecule_name": "antibody",
        "protein_target_name": "PD-1",
        "binding_metric": "Kd",
        "value": "≤10",
        "unit": "pM",
        "raw_mentions": "An antibody of the present invention can specifically bind to a PD-1 epitope when the equilibrium binding constant (K<sub>D</sub>) is ≤1 μM, ≤10 μM, ≤10 nM, ≤10 pM, or &lt;100 pM to about 1 pM, as measured by kinetic assays such as radioligand binding assays or similar assays known to those skilled in the art, such as BIAcore or Octet (BLI).\nFor example, in some embodiments, the K<sub>D </sub>is between about 1E-12 M and a K<sub>D </sub>about 1E-11 M.\nIn some embodiments, the K<sub>D </sub>is between about 1E-11 M and a K<sub>D </sub>about 1E-10 M.\nIn some embodiments, the K<sub>D </sub>is between about 1E-10 M and a K<sub>D </sub>about 1E-9 M.\nIn some embodiments, the K<sub>D </sub>is between about 1E-9 M and a K<sub>D </sub>about 1E-8 M.\nIn some embodiments, the K<sub>D </sub>is between about 1E-8 M and a K<sub>D </sub>about 1E-7 M.\nIn some embodiments, the K<sub>D </sub>is between about 1E-7 M and a K<sub>D </sub>about 1E-6 M.\nFor example, in some embodiments, the K<sub>D </sub>is about 1E-12 M while in other embodiments the K<sub>D </sub>is about 1E-11 M.\nIn some embodiments, the K<sub>D </sub>is about 1E-10 M while in other embodiments the K<sub>D </sub>is about 1E-9 M.\nIn some embodiments, the K<sub>D </sub>is about 1E-8 M while in other embodiments the K<sub>D </sub>is about 1E-7 M.\nIn some embodiments, the K<sub>D </sub>is about 1E-6 M while in other embodiments the K<sub>D </sub>is about 1E-5 M.\nIn some embodiments, for example, the K<sub>D </sub>is about 3 E-11 M, while in other embodiments the K<sub>D </sub>is about 3E-12 M."
    },
    {
        "molecule_name": "antibody",
        "protein_target_name": "PD-1",
        "binding_metric": "Kd",
        "value": "<100",
        "unit": "pM",
        "raw_mentions": "An antibody of the present invention can specifically bind to a PD-1 epitope when the equilibrium binding constant (K<sub>D</sub>) is ≤1 μM, ≤10 μM, ≤10 nM, ≤10 pM, or &lt;100 pM to about 1 pM, as measured by kinetic assays such as radioligand binding assays or similar assays known to those skilled in the art, such as BIAcore or Octet (BLI).\nFor example, in some embodiments, the K<sub>D </sub>is between about 1E-12 M and a K<sub>D </sub>about 1E-11 M.\nIn some embodiments, the K<sub>D </sub>is between about 1E-11 M and a K<sub>D </sub>about 1E-10 M.\nIn some embodiments, the K<sub>D </sub>is between about 1E-10 M and a K<sub>D </sub>about 1E-9 M.\nIn some embodiments, the K<sub>D </sub>is between about 1E-9 M and a K<sub>D </sub>about 1E-8 M.\nIn some embodiments, the K<sub>D </sub>is between about 1E-8 M and a K<sub>D </sub>about 1E-7 M.\nIn some embodiments, the K<sub>D </sub>is between about 1E-7 M and a K<sub>D </sub>about 1E-6 M.\nFor example, in some embodiments, the K<sub>D </sub>is about 1E-12 M while in other embodiments the K<sub>D </sub>is about 1E-11 M.\nIn some embodiments, the K<sub>D </sub>is about 1E-10 M while in other embodiments the K<sub>D </sub>is about 1E-9 M.\nIn some embodiments, the K<sub>D </sub>is about 1E-8 M while in other embodiments the K<sub>D </sub>is about 1E-7 M.\nIn some embodiments, the K<sub>D </sub>is about 1E-6 M while in other embodiments the K<sub>D </sub>is about 1E-5 M.\nIn some embodiments, for example, the K<sub>D </sub>is about 3 E-11 M, while in other embodiments the K<sub>D </sub>is about 3E-12 M."
    },
    {
        "molecule_name": "antibody",
        "protein_target_name": "PD-1",
        "binding_metric": "Kd",
        "value": "about 1",
        "unit": "pM",
        "raw_mentions": "An antibody of the present invention can specifically bind to a PD-1 epitope when the equilibrium binding constant (K<sub>D</sub>) is ≤1 μM, ≤10 μM, ≤10 nM, ≤10 pM, or &lt;100 pM to about 1 pM, as measured by kinetic assays such as radioligand binding assays or similar assays known to those skilled in the art, such as BIAcore or Octet (BLI).\nFor example, in some embodiments, the K<sub>D </sub>is between about 1E-12 M and a K<sub>D </sub>about 1E-11 M.\nIn some embodiments, the K<sub>D </sub>is between about 1E-11 M and a K<sub>D </sub>about 1E-10 M.\nIn some embodiments, the K<sub>D </sub>is between about 1E-10 M and a K<sub>D </sub>about 1E-9 M.\nIn some embodiments, the K<sub>D </sub>is between about 1E-9 M and a K<sub>D </sub>about 1E-8 M.\nIn some embodiments, the K<sub>D </sub>is between about 1E-8 M and a K<sub>D </sub>about 1E-7 M.\nIn some embodiments, the K<sub>D </sub>is between about 1E-7 M and a K<sub>D </sub>about 1E-6 M.\nFor example, in some embodiments, the K<sub>D </sub>is about 1E-12 M while in other embodiments the K<sub>D </sub>is about 1E-11 M.\nIn some embodiments, the K<sub>D </sub>is about 1E-10 M while in other embodiments the K<sub>D </sub>is about 1E-9 M.\nIn some embodiments, the K<sub>D </sub>is about 1E-8 M while in other embodiments the K<sub>D </sub>is about 1E-7 M.\nIn some embodiments, the K<sub>D </sub>is about 1E-6 M while in other embodiments the K<sub>D </sub>is about 1E-5 M.\nIn some embodiments, for example, the K<sub>D </sub>is about 3 E-11 M, while in other embodiments the K<sub>D </sub>is about 3E-12 M."
    },
    {
        "molecule_name": "antibody",
        "protein_target_name": "PD-1",
        "binding_metric": "Kd",
        "value": "1E-12",
        "unit": "M",
        "raw_mentions": "An antibody of the present invention can specifically bind to a PD-1 epitope when the equilibrium binding constant (K<sub>D</sub>) is ≤1 μM, ≤10 μM, ≤10 nM, ≤10 pM, or &lt;100 pM to about 1 pM, as measured by kinetic assays such as radioligand binding assays or similar assays known to those skilled in the art, such as BIAcore or Octet (BLI).\nFor example, in some embodiments, the K<sub>D </sub>is between about 1E-12 M and a K<sub>D </sub>about 1E-11 M.\nIn some embodiments, the K<sub>D </sub>is between about 1E-11 M and a K<sub>D </sub>about 1E-10 M.\nIn some embodiments, the K<sub>D </sub>is between about 1E-10 M and a K<sub>D </sub>about 1E-9 M.\nIn some embodiments, the K<sub>D </sub>is between about 1E-9 M and a K<sub>D </sub>about 1E-8 M.\nIn some embodiments, the K<sub>D </sub>is between about 1E-8 M and a K<sub>D </sub>about 1E-7 M.\nIn some embodiments, the K<sub>D </sub>is between about 1E-7 M and a K<sub>D </sub>about 1E-6 M.\nFor example, in some embodiments, the K<sub>D </sub>is about 1E-12 M while in other embodiments the K<sub>D </sub>is about 1E-11 M.\nIn some embodiments, the K<sub>D </sub>is about 1E-10 M while in other embodiments the K<sub>D </sub>is about 1E-9 M.\nIn some embodiments, the K<sub>D </sub>is about 1E-8 M while in other embodiments the K<sub>D </sub>is about 1E-7 M.\nIn some embodiments, the K<sub>D </sub>is about 1E-6 M while in other embodiments the K<sub>D </sub>is about 1E-5 M.\nIn some embodiments, for example, the K<sub>D </sub>is about 3 E-11 M, while in other embodiments the K<sub>D </sub>is about 3E-12 M."
    },
    {
        "molecule_name": "antibody",
        "protein_target_name": "PD-1",
        "binding_metric": "Kd",
        "value": "1E-11",
        "unit": "M",
        "raw_mentions": "An antibody of the present invention can specifically bind to a PD-1 epitope when the equilibrium binding constant (K<sub>D</sub>) is ≤1 μM, ≤10 μM, ≤10 nM, ≤10 pM, or &lt;100 pM to about 1 pM, as measured by kinetic assays such as radioligand binding assays or similar assays known to those skilled in the art, such as BIAcore or Octet (BLI).\nFor example, in some embodiments, the K<sub>D </sub>is between about 1E-12 M and a K<sub>D </sub>about 1E-11 M.\nIn some embodiments, the K<sub>D </sub>is between about 1E-11 M and a K<sub>D </sub>about 1E-10 M.\nIn some embodiments, the K<sub>D </sub>is between about 1E-10 M and a K<sub>D </sub>about 1E-9 M.\nIn some embodiments, the K<sub>D </sub>is between about 1E-9 M and a K<sub>D </sub>about 1E-8 M.\nIn some embodiments, the K<sub>D </sub>is between about 1E-8 M and a K<sub>D </sub>about 1E-7 M.\nIn some embodiments, the K<sub>D </sub>is between about 1E-7 M and a K<sub>D </sub>about 1E-6 M.\nFor example, in some embodiments, the K<sub>D </sub>is about 1E-12 M while in other embodiments the K<sub>D </sub>is about 1E-11 M.\nIn some embodiments, the K<sub>D </sub>is about 1E-10 M while in other embodiments the K<sub>D </sub>is about 1E-9 M.\nIn some embodiments, the K<sub>D </sub>is about 1E-8 M while in other embodiments the K<sub>D </sub>is about 1E-7 M.\nIn some embodiments, the K<sub>D </sub>is about 1E-6 M while in other embodiments the K<sub>D </sub>is about 1E-5 M.\nIn some embodiments, for example, the K<sub>D </sub>is about 3 E-11 M, while in other embodiments the K<sub>D </sub>is about 3E-12 M."
    },
    {
        "molecule_name": "antibody",
        "protein_target_name": "PD-1",
        "binding_metric": "Kd",
        "value": "1E-11",
        "unit": "M",
        "raw_mentions": "An antibody of the present invention can specifically bind to a PD-1 epitope when the equilibrium binding constant (K<sub>D</sub>) is ≤1 μM, ≤10 μM, ≤10 nM, ≤10 pM, or &lt;100 pM to about 1 pM, as measured by kinetic assays such as radioligand binding assays or similar assays known to those skilled in the art, such as BIAcore or Octet (BLI).\nFor example, in some embodiments, the K<sub>D </sub>is between about 1E-12 M and a K<sub>D </sub>about 1E-11 M.\nIn some embodiments, the K<sub>D </sub>is between about 1E-11 M and a K<sub>D </sub>about 1E-10 M.\nIn some embodiments, the K<sub>D </sub>is between about 1E-10 M and a K<sub>D </sub>about 1E-9 M.\nIn some embodiments, the K<sub>D </sub>is between about 1E-9 M and a K<sub>D </sub>about 1E-8 M.\nIn some embodiments, the K<sub>D </sub>is between about 1E-8 M and a K<sub>D </sub>about 1E-7 M.\nIn some embodiments, the K<sub>D </sub>is between about 1E-7 M and a K<sub>D </sub>about 1E-6 M.\nFor example, in some embodiments, the K<sub>D </sub>is about 1E-12 M while in other embodiments the K<sub>D </sub>is about 1E-11 M.\nIn some embodiments, the K<sub>D </sub>is about 1E-10 M while in other embodiments the K<sub>D </sub>is about 1E-9 M.\nIn some embodiments, the K<sub>D </sub>is about 1E-8 M while in other embodiments the K<sub>D </sub>is about 1E-7 M.\nIn some embodiments, the K<sub>D </sub>is about 1E-6 M while in other embodiments the K<sub>D </sub>is about 1E-5 M.\nIn some embodiments, for example, the K<sub>D </sub>is about 3 E-11 M, while in other embodiments the K<sub>D </sub>is about 3E-12 M."
    },
    {
        "molecule_name": "antibody",
        "protein_target_name": "PD-1",
        "binding_metric": "Kd",
        "value": "1E-10",
        "unit": "M",
        "raw_mentions": "An antibody of the present invention can specifically bind to a PD-1 epitope when the equilibrium binding constant (K<sub>D</sub>) is ≤1 μM, ≤10 μM, ≤10 nM, ≤10 pM, or &lt;100 pM to about 1 pM, as measured by kinetic assays such as radioligand binding assays or similar assays known to those skilled in the art, such as BIAcore or Octet (BLI).\nFor example, in some embodiments, the K<sub>D </sub>is between about 1E-12 M and a K<sub>D </sub>about 1E-11 M.\nIn some embodiments, the K<sub>D </sub>is between about 1E-11 M and a K<sub>D </sub>about 1E-10 M.\nIn some embodiments, the K<sub>D </sub>is between about 1E-10 M and a K<sub>D </sub>about 1E-9 M.\nIn some embodiments, the K<sub>D </sub>is between about 1E-9 M and a K<sub>D </sub>about 1E-8 M.\nIn some embodiments, the K<sub>D </sub>is between about 1E-8 M and a K<sub>D </sub>about 1E-7 M.\nIn some embodiments, the K<sub>D </sub>is between about 1E-7 M and a K<sub>D </sub>about 1E-6 M.\nFor example, in some embodiments, the K<sub>D </sub>is about 1E-12 M while in other embodiments the K<sub>D </sub>is about 1E-11 M.\nIn some embodiments, the K<sub>D </sub>is about 1E-10 M while in other embodiments the K<sub>D </sub>is about 1E-9 M.\nIn some embodiments, the K<sub>D </sub>is about 1E-8 M while in other embodiments the K<sub>D </sub>is about 1E-7 M.\nIn some embodiments, the K<sub>D </sub>is about 1E-6 M while in other embodiments the K<sub>D </sub>is about 1E-5 M.\nIn some embodiments, for example, the K<sub>D </sub>is about 3 E-11 M, while in other embodiments the K<sub>D </sub>is about 3E-12 M."
    },
    {
        "molecule_name": "antibody",
        "protein_target_name": "PD-1",
        "binding_metric": "Kd",
        "value": "1E-10",
        "unit": "M",
        "raw_mentions": "An antibody of the present invention can specifically bind to a PD-1 epitope when the equilibrium binding constant (K<sub>D</sub>) is ≤1 μM, ≤10 μM, ≤10 nM, ≤10 pM, or &lt;100 pM to about 1 pM, as measured by kinetic assays such as radioligand binding assays or similar assays known to those skilled in the art, such as BIAcore or Octet (BLI).\nFor example, in some embodiments, the K<sub>D </sub>is between about 1E-12 M and a K<sub>D </sub>about 1E-11 M.\nIn some embodiments, the K<sub>D </sub>is between about 1E-11 M and a K<sub>D </sub>about 1E-10 M.\nIn some embodiments, the K<sub>D </sub>is between about 1E-10 M and a K<sub>D </sub>about 1E-9 M.\nIn some embodiments, the K<sub>D </sub>is between about 1E-9 M and a K<sub>D </sub>about 1E-8 M.\nIn some embodiments, the K<sub>D </sub>is between about 1E-8 M and a K<sub>D </sub>about 1E-7 M.\nIn some embodiments, the K<sub>D </sub>is between about 1E-7 M and a K<sub>D </sub>about 1E-6 M.\nFor example, in some embodiments, the K<sub>D </sub>is about 1E-12 M while in other embodiments the K<sub>D </sub>is about 1E-11 M.\nIn some embodiments, the K<sub>D </sub>is about 1E-10 M while in other embodiments the K<sub>D </sub>is about 1E-9 M.\nIn some embodiments, the K<sub>D </sub>is about 1E-8 M while in other embodiments the K<sub>D </sub>is about 1E-7 M.\nIn some embodiments, the K<sub>D </sub>is about 1E-6 M while in other embodiments the K<sub>D </sub>is about 1E-5 M.\nIn some embodiments, for example, the K<sub>D </sub>is about 3 E-11 M, while in other embodiments the K<sub>D </sub>is about 3E-12 M."
    },
    {
        "molecule_name": "antibody",
        "protein_target_name": "PD-1",
        "binding_metric": "Kd",
        "value": "1E-9",
        "unit": "M",
        "raw_mentions": "An antibody of the present invention can specifically bind to a PD-1 epitope when the equilibrium binding constant (K<sub>D</sub>) is ≤1 μM, ≤10 μM, ≤10 nM, ≤10 pM, or &lt;100 pM to about 1 pM, as measured by kinetic assays such as radioligand binding assays or similar assays known to those skilled in the art, such as BIAcore or Octet (BLI).\nFor example, in some embodiments, the K<sub>D </sub>is between about 1E-12 M and a K<sub>D </sub>about 1E-11 M.\nIn some embodiments, the K<sub>D </sub>is between about 1E-11 M and a K<sub>D </sub>about 1E-10 M.\nIn some embodiments, the K<sub>D </sub>is between about 1E-10 M and a K<sub>D </sub>about 1E-9 M.\nIn some embodiments, the K<sub>D </sub>is between about 1E-9 M and a K<sub>D </sub>about 1E-8 M.\nIn some embodiments, the K<sub>D </sub>is between about 1E-8 M and a K<sub>D </sub>about 1E-7 M.\nIn some embodiments, the K<sub>D </sub>is between about 1E-7 M and a K<sub>D </sub>about 1E-6 M.\nFor example, in some embodiments, the K<sub>D </sub>is about 1E-12 M while in other embodiments the K<sub>D </sub>is about 1E-11 M.\nIn some embodiments, the K<sub>D </sub>is about 1E-10 M while in other embodiments the K<sub>D </sub>is about 1E-9 M.\nIn some embodiments, the K<sub>D </sub>is about 1E-8 M while in other embodiments the K<sub>D </sub>is about 1E-7 M.\nIn some embodiments, the K<sub>D </sub>is about 1E-6 M while in other embodiments the K<sub>D </sub>is about 1E-5 M.\nIn some embodiments, for example, the K<sub>D </sub>is about 3 E-11 M, while in other embodiments the K<sub>D </sub>is about 3E-12 M."
    },
    {
        "molecule_name": "antibody",
        "protein_target_name": "PD-1",
        "binding_metric": "Kd",
        "value": "1E-9",
        "unit": "M",
        "raw_mentions": "An antibody of the present invention can specifically bind to a PD-1 epitope when the equilibrium binding constant (K<sub>D</sub>) is ≤1 μM, ≤10 μM, ≤10 nM, ≤10 pM, or &lt;100 pM to about 1 pM, as measured by kinetic assays such as radioligand binding assays or similar assays known to those skilled in the art, such as BIAcore or Octet (BLI).\nFor example, in some embodiments, the K<sub>D </sub>is between about 1E-12 M and a K<sub>D </sub>about 1E-11 M.\nIn some embodiments, the K<sub>D </sub>is between about 1E-11 M and a K<sub>D </sub>about 1E-10 M.\nIn some embodiments, the K<sub>D </sub>is between about 1E-10 M and a K<sub>D </sub>about 1E-9 M.\nIn some embodiments, the K<sub>D </sub>is between about 1E-9 M and a K<sub>D </sub>about 1E-8 M.\nIn some embodiments, the K<sub>D </sub>is between about 1E-8 M and a K<sub>D </sub>about 1E-7 M.\nIn some embodiments, the K<sub>D </sub>is between about 1E-7 M and a K<sub>D </sub>about 1E-6 M.\nFor example, in some embodiments, the K<sub>D </sub>is about 1E-12 M while in other embodiments the K<sub>D </sub>is about 1E-11 M.\nIn some embodiments, the K<sub>D </sub>is about 1E-10 M while in other embodiments the K<sub>D </sub>is about 1E-9 M.\nIn some embodiments, the K<sub>D </sub>is about 1E-8 M while in other embodiments the K<sub>D </sub>is about 1E-7 M.\nIn some embodiments, the K<sub>D </sub>is about 1E-6 M while in other embodiments the K<sub>D </sub>is about 1E-5 M.\nIn some embodiments, for example, the K<sub>D </sub>is about 3 E-11 M, while in other embodiments the K<sub>D </sub>is about 3E-12 M."
    },
    {
        "molecule_name": "antibody",
        "protein_target_name": "PD-1",
        "binding_metric": "Kd",
        "value": "1E-8",
        "unit": "M",
        "raw_mentions": "An antibody of the present invention can specifically bind to a PD-1 epitope when the equilibrium binding constant (K<sub>D</sub>) is ≤1 μM, ≤10 μM, ≤10 nM, ≤10 pM, or &lt;100 pM to about 1 pM, as measured by kinetic assays such as radioligand binding assays or similar assays known to those skilled in the art, such as BIAcore or Octet (BLI).\nFor example, in some embodiments, the K<sub>D </sub>is between about 1E-12 M and a K<sub>D </sub>about 1E-11 M.\nIn some embodiments, the K<sub>D </sub>is between about 1E-11 M and a K<sub>D </sub>about 1E-10 M.\nIn some embodiments, the K<sub>D </sub>is between about 1E-10 M and a K<sub>D </sub>about 1E-9 M.\nIn some embodiments, the K<sub>D </sub>is between about 1E-9 M and a K<sub>D </sub>about 1E-8 M.\nIn some embodiments, the K<sub>D </sub>is between about 1E-8 M and a K<sub>D </sub>about 1E-7 M.\nIn some embodiments, the K<sub>D </sub>is between about 1E-7 M and a K<sub>D </sub>about 1E-6 M.\nFor example, in some embodiments, the K<sub>D </sub>is about 1E-12 M while in other embodiments the K<sub>D </sub>is about 1E-11 M.\nIn some embodiments, the K<sub>D </sub>is about 1E-10 M while in other embodiments the K<sub>D </sub>is about 1E-9 M.\nIn some embodiments, the K<sub>D </sub>is about 1E-8 M while in other embodiments the K<sub>D </sub>is about 1E-7 M.\nIn some embodiments, the K<sub>D </sub>is about 1E-6 M while in other embodiments the K<sub>D </sub>is about 1E-5 M.\nIn some embodiments, for example, the K<sub>D </sub>is about 3 E-11 M, while in other embodiments the K<sub>D </sub>is about 3E-12 M."
    },
    {
        "molecule_name": "antibody",
        "protein_target_name": "PD-1",
        "binding_metric": "Kd",
        "value": "1E-8",
        "unit": "M",
        "raw_mentions": "An antibody of the present invention can specifically bind to a PD-1 epitope when the equilibrium binding constant (K<sub>D</sub>) is ≤1 μM, ≤10 μM, ≤10 nM, ≤10 pM, or &lt;100 pM to about 1 pM, as measured by kinetic assays such as radioligand binding assays or similar assays known to those skilled in the art, such as BIAcore or Octet (BLI).\nFor example, in some embodiments, the K<sub>D </sub>is between about 1E-12 M and a K<sub>D </sub>about 1E-11 M.\nIn some embodiments, the K<sub>D </sub>is between about 1E-11 M and a K<sub>D </sub>about 1E-10 M.\nIn some embodiments, the K<sub>D </sub>is between about 1E-10 M and a K<sub>D </sub>about 1E-9 M.\nIn some embodiments, the K<sub>D </sub>is between about 1E-9 M and a K<sub>D </sub>about 1E-8 M.\nIn some embodiments, the K<sub>D </sub>is between about 1E-8 M and a K<sub>D </sub>about 1E-7 M.\nIn some embodiments, the K<sub>D </sub>is between about 1E-7 M and a K<sub>D </sub>about 1E-6 M.\nFor example, in some embodiments, the K<sub>D </sub>is about 1E-12 M while in other embodiments the K<sub>D </sub>is about 1E-11 M.\nIn some embodiments, the K<sub>D </sub>is about 1E-10 M while in other embodiments the K<sub>D </sub>is about 1E-9 M.\nIn some embodiments, the K<sub>D </sub>is about 1E-8 M while in other embodiments the K<sub>D </sub>is about 1E-7 M.\nIn some embodiments, the K<sub>D </sub>is about 1E-6 M while in other embodiments the K<sub>D </sub>is about 1E-5 M.\nIn some embodiments, for example, the K<sub>D </sub>is about 3 E-11 M, while in other embodiments the K<sub>D </sub>is about 3E-12 M."
    },
    {
        "molecule_name": "antibody",
        "protein_target_name": "PD-1",
        "binding_metric": "Kd",
        "value": "1E-7",
        "unit": "M",
        "raw_mentions": "An antibody of the present invention can specifically bind to a PD-1 epitope when the equilibrium binding constant (K<sub>D</sub>) is ≤1 μM, ≤10 μM, ≤10 nM, ≤10 pM, or &lt;100 pM to about 1 pM, as measured by kinetic assays such as radioligand binding assays or similar assays known to those skilled in the art, such as BIAcore or Octet (BLI).\nFor example, in some embodiments, the K<sub>D </sub>is between about 1E-12 M and a K<sub>D </sub>about 1E-11 M.\nIn some embodiments, the K<sub>D </sub>is between about 1E-11 M and a K<sub>D </sub>about 1E-10 M.\nIn some embodiments, the K<sub>D </sub>is between about 1E-10 M and a K<sub>D </sub>about 1E-9 M.\nIn some embodiments, the K<sub>D </sub>is between about 1E-9 M and a K<sub>D </sub>about 1E-8 M.\nIn some embodiments, the K<sub>D </sub>is between about 1E-8 M and a K<sub>D </sub>about 1E-7 M.\nIn some embodiments, the K<sub>D </sub>is between about 1E-7 M and a K<sub>D </sub>about 1E-6 M.\nFor example, in some embodiments, the K<sub>D </sub>is about 1E-12 M while in other embodiments the K<sub>D </sub>is about 1E-11 M.\nIn some embodiments, the K<sub>D </sub>is about 1E-10 M while in other embodiments the K<sub>D </sub>is about 1E-9 M.\nIn some embodiments, the K<sub>D </sub>is about 1E-8 M while in other embodiments the K<sub>D </sub>is about 1E-7 M.\nIn some embodiments, the K<sub>D </sub>is about 1E-6 M while in other embodiments the K<sub>D </sub>is about 1E-5 M.\nIn some embodiments, for example, the K<sub>D </sub>is about 3 E-11 M, while in other embodiments the K<sub>D </sub>is about 3E-12 M."
    },
    {
        "molecule_name": "antibody",
        "protein_target_name": "PD-1",
        "binding_metric": "Kd",
        "value": "1E-7",
        "unit": "M",
        "raw_mentions": "An antibody of the present invention can specifically bind to a PD-1 epitope when the equilibrium binding constant (K<sub>D</sub>) is ≤1 μM, ≤10 μM, ≤10 nM, ≤10 pM, or &lt;100 pM to about 1 pM, as measured by kinetic assays such as radioligand binding assays or similar assays known to those skilled in the art, such as BIAcore or Octet (BLI).\nFor example, in some embodiments, the K<sub>D </sub>is between about 1E-12 M and a K<sub>D </sub>about 1E-11 M.\nIn some embodiments, the K<sub>D </sub>is between about 1E-11 M and a K<sub>D </sub>about 1E-10 M.\nIn some embodiments, the K<sub>D </sub>is between about 1E-10 M and a K<sub>D </sub>about 1E-9 M.\nIn some embodiments, the K<sub>D </sub>is between about 1E-9 M and a K<sub>D </sub>about 1E-8 M.\nIn some embodiments, the K<sub>D </sub>is between about 1E-8 M and a K<sub>D </sub>about 1E-7 M.\nIn some embodiments, the K<sub>D </sub>is between about 1E-7 M and a K<sub>D </sub>about 1E-6 M.\nFor example, in some embodiments, the K<sub>D </sub>is about 1E-12 M while in other embodiments the K<sub>D </sub>is about 1E-11 M.\nIn some embodiments, the K<sub>D </sub>is about 1E-10 M while in other embodiments the K<sub>D </sub>is about 1E-9 M.\nIn some embodiments, the K<sub>D </sub>is about 1E-8 M while in other embodiments the K<sub>D </sub>is about 1E-7 M.\nIn some embodiments, the K<sub>D </sub>is about 1E-6 M while in other embodiments the K<sub>D </sub>is about 1E-5 M.\nIn some embodiments, for example, the K<sub>D </sub>is about 3 E-11 M, while in other embodiments the K<sub>D </sub>is about 3E-12 M."
    },
    {
        "molecule_name": "antibody",
        "protein_target_name": "PD-1",
        "binding_metric": "Kd",
        "value": "1E-6",
        "unit": "M",
        "raw_mentions": "An antibody of the present invention can specifically bind to a PD-1 epitope when the equilibrium binding constant (K<sub>D</sub>) is ≤1 μM, ≤10 μM, ≤10 nM, ≤10 pM, or &lt;100 pM to about 1 pM, as measured by kinetic assays such as radioligand binding assays or similar assays known to those skilled in the art, such as BIAcore or Octet (BLI).\nFor example, in some embodiments, the K<sub>D </sub>is between about 1E-12 M and a K<sub>D </sub>about 1E-11 M.\nIn some embodiments, the K<sub>D </sub>is between about 1E-11 M and a K<sub>D </sub>about 1E-10 M.\nIn some embodiments, the K<sub>D </sub>is between about 1E-10 M and a K<sub>D </sub>about 1E-9 M.\nIn some embodiments, the K<sub>D </sub>is between about 1E-9 M and a K<sub>D </sub>about 1E-8 M.\nIn some embodiments, the K<sub>D </sub>is between about 1E-8 M and a K<sub>D </sub>about 1E-7 M.\nIn some embodiments, the K<sub>D </sub>is between about 1E-7 M and a K<sub>D </sub>about 1E-6 M.\nFor example, in some embodiments, the K<sub>D </sub>is about 1E-12 M while in other embodiments the K<sub>D </sub>is about 1E-11 M.\nIn some embodiments, the K<sub>D </sub>is about 1E-10 M while in other embodiments the K<sub>D </sub>is about 1E-9 M.\nIn some embodiments, the K<sub>D </sub>is about 1E-8 M while in other embodiments the K<sub>D </sub>is about 1E-7 M.\nIn some embodiments, the K<sub>D </sub>is about 1E-6 M while in other embodiments the K<sub>D </sub>is about 1E-5 M.\nIn some embodiments, for example, the K<sub>D </sub>is about 3 E-11 M, while in other embodiments the K<sub>D </sub>is about 3E-12 M."
    },
    {
        "molecule_name": "antibody",
        "protein_target_name": "PD-1",
        "binding_metric": "Kd",
        "value": "1E-6",
        "unit": "M",
        "raw_mentions": "An antibody of the present invention can specifically bind to a PD-1 epitope when the equilibrium binding constant (K<sub>D</sub>) is ≤1 μM, ≤10 μM, ≤10 nM, ≤10 pM, or &lt;100 pM to about 1 pM, as measured by kinetic assays such as radioligand binding assays or similar assays known to those skilled in the art, such as BIAcore or Octet (BLI).\nFor example, in some embodiments, the K<sub>D </sub>is between about 1E-12 M and a K<sub>D </sub>about 1E-11 M.\nIn some embodiments, the K<sub>D </sub>is between about 1E-11 M and a K<sub>D </sub>about 1E-10 M.\nIn some embodiments, the K<sub>D </sub>is between about 1E-10 M and a K<sub>D </sub>about 1E-9 M.\nIn some embodiments, the K<sub>D </sub>is between about 1E-9 M and a K<sub>D </sub>about 1E-8 M.\nIn some embodiments, the K<sub>D </sub>is between about 1E-8 M and a K<sub>D </sub>about 1E-7 M.\nIn some embodiments, the K<sub>D </sub>is between about 1E-7 M and a K<sub>D </sub>about 1E-6 M.\nFor example, in some embodiments, the K<sub>D </sub>is about 1E-12 M while in other embodiments the K<sub>D </sub>is about 1E-11 M.\nIn some embodiments, the K<sub>D </sub>is about 1E-10 M while in other embodiments the K<sub>D </sub>is about 1E-9 M.\nIn some embodiments, the K<sub>D </sub>is about 1E-8 M while in other embodiments the K<sub>D </sub>is about 1E-7 M.\nIn some embodiments, the K<sub>D </sub>is about 1E-6 M while in other embodiments the K<sub>D </sub>is about 1E-5 M.\nIn some embodiments, for example, the K<sub>D </sub>is about 3 E-11 M, while in other embodiments the K<sub>D </sub>is about 3E-12 M."
    },
    {
        "molecule_name": "antibody",
        "protein_target_name": "PD-1",
        "binding_metric": "Kd",
        "value": "1E-5",
        "unit": "M",
        "raw_mentions": "An antibody of the present invention can specifically bind to a PD-1 epitope when the equilibrium binding constant (K<sub>D</sub>) is ≤1 μM, ≤10 μM, ≤10 nM, ≤10 pM, or &lt;100 pM to about 1 pM, as measured by kinetic assays such as radioligand binding assays or similar assays known to those skilled in the art, such as BIAcore or Octet (BLI).\nFor example, in some embodiments, the K<sub>D </sub>is between about 1E-12 M and a K<sub>D </sub>about 1E-11 M.\nIn some embodiments, the K<sub>D </sub>is between about 1E-11 M and a K<sub>D </sub>about 1E-10 M.\nIn some embodiments, the K<sub>D </sub>is between about 1E-10 M and a K<sub>D </sub>about 1E-9 M.\nIn some embodiments, the K<sub>D </sub>is between about 1E-9 M and a K<sub>D </sub>about 1E-8 M.\nIn some embodiments, the K<sub>D </sub>is between about 1E-8 M and a K<sub>D </sub>about 1E-7 M.\nIn some embodiments, the K<sub>D </sub>is between about 1E-7 M and a K<sub>D </sub>about 1E-6 M.\nFor example, in some embodiments, the K<sub>D </sub>is about 1E-12 M while in other embodiments the K<sub>D </sub>is about 1E-11 M.\nIn some embodiments, the K<sub>D </sub>is about 1E-10 M while in other embodiments the K<sub>D </sub>is about 1E-9 M.\nIn some embodiments, the K<sub>D </sub>is about 1E-8 M while in other embodiments the K<sub>D </sub>is about 1E-7 M.\nIn some embodiments, the K<sub>D </sub>is about 1E-6 M while in other embodiments the K<sub>D </sub>is about 1E-5 M.\nIn some embodiments, for example, the K<sub>D </sub>is about 3 E-11 M, while in other embodiments the K<sub>D </sub>is about 3E-12 M."
    },
    {
        "molecule_name": "antibody",
        "protein_target_name": "PD-1",
        "binding_metric": "Kd",
        "value": "3 E-11",
        "unit": "M",
        "raw_mentions": "An antibody of the present invention can specifically bind to a PD-1 epitope when the equilibrium binding constant (K<sub>D</sub>) is ≤1 μM, ≤10 μM, ≤10 nM, ≤10 pM, or &lt;100 pM to about 1 pM, as measured by kinetic assays such as radioligand binding assays or similar assays known to those skilled in the art, such as BIAcore or Octet (BLI).\nFor example, in some embodiments, the K<sub>D </sub>is between about 1E-12 M and a K<sub>D </sub>about 1E-11 M.\nIn some embodiments, the K<sub>D </sub>is between about 1E-11 M and a K<sub>D </sub>about 1E-10 M.\nIn some embodiments, the K<sub>D </sub>is between about 1E-10 M and a K<sub>D </sub>about 1E-9 M.\nIn some embodiments, the K<sub>D </sub>is between about 1E-9 M and a K<sub>D </sub>about 1E-8 M.\nIn some embodiments, the K<sub>D </sub>is between about 1E-8 M and a K<sub>D </sub>about 1E-7 M.\nIn some embodiments, the K<sub>D </sub>is between about 1E-7 M and a K<sub>D </sub>about 1E-6 M.\nFor example, in some embodiments, the K<sub>D </sub>is about 1E-12 M while in other embodiments the K<sub>D </sub>is about 1E-11 M.\nIn some embodiments, the K<sub>D </sub>is about 1E-10 M while in other embodiments the K<sub>D </sub>is about 1E-9 M.\nIn some embodiments, the K<sub>D </sub>is about 1E-8 M while in other embodiments the K<sub>D </sub>is about 1E-7 M.\nIn some embodiments, the K<sub>D </sub>is about 1E-6 M while in other embodiments the K<sub>D </sub>is about 1E-5 M.\nIn some embodiments, for example, the K<sub>D </sub>is about 3 E-11 M, while in other embodiments the K<sub>D </sub>is about 3E-12 M."
    },
    {
        "molecule_name": "antibody",
        "protein_target_name": "PD-1",
        "binding_metric": "Kd",
        "value": "3E-12",
        "unit": "M",
        "raw_mentions": "An antibody of the present invention can specifically bind to a PD-1 epitope when the equilibrium binding constant (K<sub>D</sub>) is ≤1 μM, ≤10 μM, ≤10 nM, ≤10 pM, or &lt;100 pM to about 1 pM, as measured by kinetic assays such as radioligand binding assays or similar assays known to those skilled in the art, such as BIAcore or Octet (BLI).\nFor example, in some embodiments, the K<sub>D </sub>is between about 1E-12 M and a K<sub>D </sub>about 1E-11 M.\nIn some embodiments, the K<sub>D </sub>is between about 1E-11 M and a K<sub>D </sub>about 1E-10 M.\nIn some embodiments, the K<sub>D </sub>is between about 1E-10 M and a K<sub>D </sub>about 1E-9 M.\nIn some embodiments, the K<sub>D </sub>is between about 1E-9 M and a K<sub>D </sub>about 1E-8 M.\nIn some embodiments, the K<sub>D </sub>is between about 1E-8 M and a K<sub>D </sub>about 1E-7 M.\nIn some embodiments, the K<sub>D </sub>is between about 1E-7 M and a K<sub>D </sub>about 1E-6 M.\nFor example, in some embodiments, the K<sub>D </sub>is about 1E-12 M while in other embodiments the K<sub>D </sub>is about 1E-11 M.\nIn some embodiments, the K<sub>D </sub>is about 1E-10 M while in other embodiments the K<sub>D </sub>is about 1E-9 M.\nIn some embodiments, the K<sub>D </sub>is about 1E-8 M while in other embodiments the K<sub>D </sub>is about 1E-7 M.\nIn some embodiments, the K<sub>D </sub>is about 1E-6 M while in other embodiments the K<sub>D </sub>is about 1E-5 M.\nIn some embodiments, for example, the K<sub>D </sub>is about 3 E-11 M, while in other embodiments the K<sub>D </sub>is about 3E-12 M."
    }
]